Roche’s Actemra Scores New Indication In Rare Autoimmune Disease

SSc-ILD Indication Comes With Biosimilar Competition On The Horizon

 
• By Alaric DeArment
  
lung illustration
Roche received FDA approval for interstitial lung disease in the rare autoimmune disease systemic sclerosis • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Business

More from Scrip